| (R)-noradrenaline | multiple interactions | EXP | | 6480464 | ANXA1 affects the reaction [Norepinephrine results in decreased secretion of IL6 protein] | CTD | PMID:16835395 |
| 1,4-phenylenediamine | increases expression | ISO | RGD:730873 | 6480464 | 4-phenylenediamine results in increased expression of ANXA1 mRNA | CTD | PMID:16314067 |
| 1-chloro-2,4-dinitrobenzene | increases expression | ISO | RGD:730873 | 6480464 | Dinitrochlorobenzene results in increased expression of ANXA1 mRNA | CTD | PMID:16314067 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of ANXA1 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:2118 | 6480464 | Ethinyl Estradiol results in increased expression of ANXA1 mRNA | CTD | PMID:17557909 |
| 17beta-estradiol | increases expression | ISO | RGD:730873 | 6480464 | Estradiol results in increased expression of ANXA1 mRNA | CTD | PMID:23373633 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ANXA1 mRNA | CTD | PMID:15667827 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:2118 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ANXA1 mRNA | CTD | PMID:20959002 PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ANXA1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:2118 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ANXA1 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:2118 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ANXA1 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:730873 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ANXA1 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ANXA1 mRNA | CTD | PMID:15667827 PMID:19770486 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ANXA1 mRNA | CTD | PMID:17035482 PMID:15591033 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ANXA1 mRNA | CTD | PMID:19770486 PMID:15667827 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ANXA1 mRNA | CTD | PMID:15591033 PMID:17035482 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of ANXA1 mRNA | CTD | PMID:17982090 |
| 3H-1,2-dithiole-3-thione | decreases expression | ISO | RGD:2118 | 6480464 | 1,2-dithiol-3-thione results in decreased expression of ANXA1 mRNA | CTD | PMID:19162173 |
| 5-azacytidine | decreases expression | ISO | RGD:2118 | 6480464 | Azacitidine results in decreased expression of ANXA1 protein | CTD | PMID:17105402 |
| 5-fluorouracil | affects response to substance | ISO | RGD:730873 | 6480464 | ANXA1 protein affects the susceptibility to Fluorouracil | CTD | PMID:15352031 PMID:16217747 |
| 5-fluorouracil | affects response to substance | ISO | RGD:730873 | 6480464 | ANXA1 protein affects the susceptibility to Fluorouracil | CTD | PMID:16217747 PMID:15352031 |
| 5-fluorouracil | decreases expression | ISO | RGD:730873 | 6480464 | Fluorouracil results in decreased expression of ANXA1 protein | CTD | PMID:15352031 |
| 7,12-dimethyltetraphene | increases expression | ISO | RGD:2118 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ANXA1 protein | CTD | PMID:22248470 |
| 7,12-dimethyltetraphene | increases expression | ISO | RGD:2118 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ANXA1 mRNA | CTD | PMID:12376462 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:2118 | 6480464 | [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of ANXA1 protein | CTD | PMID:22248470 |
| aflatoxin B1 | affects expression | ISO | RGD:730873 | 6480464 | Aflatoxin B1 affects the expression of ANXA1 protein | CTD | PMID:20106945 |
| aflatoxin B1 | increases expression | ISO | RGD:730873 | 6480464 | Aflatoxin B1 results in increased expression of ANXA1 mRNA | CTD | PMID:22100608 |
| aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of ANXA1 mRNA | CTD | PMID:19770486 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:730873 | 6480464 | Thiophenes analog promotes the reaction [Tretinoin results in increased expression of ANXA1 mRNA] | CTD | PMID:16140955 |
| all-trans-retinoic acid | increases expression | ISO | RGD:730873 | 6480464 | Tretinoin results in increased expression of ANXA1 mRNA | CTD | PMID:21934132 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:730873 | 6480464 | Tretinoin results in increased expression of ANXA1 mRNA | CTD | PMID:15982314 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:730873 | 6480464 | Tretinoin results in increased expression of ANXA1 mRNA | CTD | PMID:15982314 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:730873 | 6480464 | Tretinoin results in increased expression of ANXA1 mRNA | CTD | PMID:16140955 PMID:15982314 |
| ammonium chloride | affects expression | ISO | RGD:2118 | 6480464 | Ammonium Chloride affects the expression of ANXA1 mRNA | CTD | PMID:16483693 |
| aniline | increases nitrosation | ISO | RGD:2118 | 6480464 | aniline results in increased nitrosation of ANXA1 protein | CTD | PMID:21708182 |
| anthracen-2-amine | increases expression | ISO | RGD:2118 | 6480464 | 2-anthramine results in increased expression of ANXA1 mRNA | CTD | PMID:23038007 |
| arsenic atom | decreases expression | ISO | RGD:730873 | 6480464 | Arsenic results in decreased expression of ANXA1 protein | CTD | PMID:19818359 |
| arsenite(3-) | affects activity | ISO | RGD:2118 | 6480464 | arsenite affects the activity of ANXA1 protein | CTD | PMID:20655937 |
| arsenite(3-) | multiple interactions | ISO | RGD:2118 | 6480464 | arsenite affects the reaction [[Magnesium co-treated with Adenosine Triphosphate] affects the activity of ANXA1 protein] | CTD | PMID:20655937 |
| ATP | multiple interactions | ISO | RGD:2118 | 6480464 | Cadmium affects the reaction [[Magnesium co-treated with Adenosine Triphosphate] affects the activity of ANXA1 protein]; more ... | CTD | PMID:20655937 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of ANXA1 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of ANXA1 mRNA | CTD | PMID:22228805 |
| bilirubin | decreases expression | ISO | RGD:730873 | 6480464 | Bilirubin results in decreased expression of ANXA1 mRNA | CTD | PMID:20196124 |
| cadmium atom | decreases expression | ISO | RGD:730873 | 6480464 | Cadmium results in decreased expression of ANXA1 mRNA | CTD | PMID:16439709 |
| cadmium atom | multiple interactions | ISO | RGD:2118 | 6480464 | Cadmium affects the reaction [[Magnesium co-treated with Adenosine Triphosphate] affects the activity of ANXA1 protein] | CTD | PMID:20655937 |
| cadmium atom | affects activity | ISO | RGD:2118 | 6480464 | Cadmium affects the activity of ANXA1 protein | CTD | PMID:20655937 |
| cadmium sulfate | increases expression | ISO | RGD:730873 | 6480464 | cadmium sulfate results in increased expression of ANXA1 mRNA | CTD | PMID:12064557 |
| calcium atom | affects activity | ISO | RGD:2118 | 6480464 | Calcium affects the activity of ANXA1 protein | CTD | PMID:20655937 |
| calcium(0) | affects activity | ISO | RGD:2118 | 6480464 | Calcium affects the activity of ANXA1 protein | CTD | PMID:20655937 |
| carbonyl sulfide | increases expression | ISO | RGD:2118 | 6480464 | carbonyl sulfide results in increased expression of ANXA1 mRNA | CTD | PMID:19395590 |
| carrageenan | affects response to substance | EXP | | 6480464 | ANXA1 protein affects the susceptibility to Carrageenan | CTD | PMID:12475898 |
| carrageenan | multiple interactions | EXP | | 6480464 | ANXA1 protein affects the susceptibility to [Dexamethasone co-treated with Carrageenan] | CTD | PMID:12475898 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANXA1 mRNA | CTD | PMID:20938992 |
| chromium(6+) | multiple interactions | ISO | RGD:2118 | 6480464 | chromium hexavalent ion affects the reaction [[Magnesium co-treated with Adenosine Triphosphate] affects the activity of ANXA1 protein] | CTD | PMID:20655937 |
| chromium(6+) | affects activity | ISO | RGD:2118 | 6480464 | chromium hexavalent ion affects the activity of ANXA1 protein | CTD | PMID:20655937 |
| cisplatin | increases expression | ISO | RGD:730873 | 6480464 | Cisplatin results in increased expression of ANXA1 protein | CTD | PMID:21924258 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of ANXA1 mRNA | CTD | PMID:21151649 |
| cisplatin | affects response to substance | ISO | RGD:730873 | 6480464 | ANXA1 protein affects the susceptibility to Cisplatin | CTD | PMID:16217747 |
| copper atom | affects binding | ISO | RGD:730873 | 6480464 | ANXA1 protein binds to Copper | CTD | PMID:14534351 |
| copper(0) | affects binding | ISO | RGD:730873 | 6480464 | ANXA1 protein binds to Copper | CTD | PMID:14534351 |
| copper(2+) sulfate | increases expression | ISO | RGD:730873 | 6480464 | Copper Sulfate results in increased expression of ANXA1 mRNA | CTD | PMID:19549813 |
| cyclosporin A | increases expression | ISO | RGD:730873 | 6480464 | Cyclosporine results in increased expression of ANXA1 mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of ANXA1 mRNA | CTD | PMID:19770486 |
| D-penicillamine | decreases expression | ISO | RGD:2118 | 6480464 | Penicillamine results in decreased expression of ANXA1 mRNA | CTD | PMID:19575532 |
| D-penicillamine | increases expression | ISO | RGD:2118 | 6480464 | Penicillamine results in increased expression of ANXA1 mRNA | CTD | PMID:19575532 |
| dexamethasone | multiple interactions | ISO | RGD:730873 | 6480464 | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Dexamethasone results in increased phosphorylation of ANXA1 protein]; more ... | CTD | PMID:10807665 |
| dexamethasone | affects response to substance | ISO | RGD:2118 | 6480464 | ANXA1 protein affects the susceptibility to Dexamethasone | CTD | PMID:15472012 |
| dexamethasone | multiple interactions | EXP | | 6480464 | ANXA1 protein affects the susceptibility to [Dexamethasone co-treated with Carrageenan] | CTD | PMID:12475898 |
| dexamethasone | affects response to substance | EXP | | 6480464 | ANXA1 protein affects the susceptibility to Dexamethasone | CTD | PMID:12475898 |
| dexamethasone | increases phosphorylation | ISO | RGD:730873 | 6480464 | Dexamethasone results in increased phosphorylation of ANXA1 protein | CTD | PMID:10807665 |
| dexamethasone | increases localization | ISO | RGD:730873 | 6480464 | Dexamethasone results in increased localization of ANXA1 protein modified form | CTD | PMID:10807665 |
| dexamethasone | increases expression | ISO | RGD:730873 | 6480464 | Dexamethasone results in increased expression of ANXA1 protein | CTD | PMID:10807665 |
| dexamethasone | multiple interactions | ISO | RGD:730873 | 6480464 | ANXA1 protein inhibits the reaction [Dexamethasone results in decreased susceptibility to IL8 protein] | CTD | PMID:7522859 |
| diarsenic trioxide | multiple interactions | ISO | RGD:730873 | 6480464 | arsenic trioxide results in increased expression of and results in increased secretion of ANXA1 protein | CTD | PMID:18081892 |
| diarsenic trioxide | increases expression | ISO | RGD:730873 | 6480464 | arsenic trioxide results in increased expression of ANXA1 mRNA | CTD | PMID:22521957 |
| diazoxide | multiple interactions | EXP | | 6480464 | ANXA1 affects the reaction [Isoproterenol results in decreased secretion of IL6 protein] | CTD | PMID:16835395 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of ANXA1 mRNA | CTD | PMID:20003209 |
| dibutyl phthalate | increases expression | ISO | RGD:2118 | 6480464 | Dibutyl Phthalate results in increased expression of ANXA1 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of ANXA1 mRNA | CTD | PMID:17361019 PMID:21266533 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of ANXA1 mRNA | CTD | PMID:21266533 |
| disodium selenite | increases expression | ISO | RGD:730873 | 6480464 | Sodium Selenite results in increased expression of ANXA1 mRNA | CTD | PMID:18175754 |
| diuron | decreases expression | ISO | RGD:2118 | 6480464 | Diuron results in decreased expression of ANXA1 mRNA | CTD | PMID:21551480 |
| ethanol | decreases expression | ISO | RGD:2118 | 6480464 | Ethanol results in decreased expression of ANXA1 mRNA | CTD | PMID:16946407 |
| ethanol | decreases expression | EXP | | 6480464 | Ethanol results in decreased expression of ANXA1 mRNA | CTD | PMID:15513904 |
| fluoxetine | decreases expression | ISO | RGD:2118 | 6480464 | Fluoxetine results in decreased expression of ANXA1 mRNA | CTD | PMID:21852994 |
| flurbiprofen | increases expression | EXP | | 6480464 | Flurbiprofen results in increased expression of ANXA1 mRNA | CTD | PMID:16949054 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANXA1 mRNA | CTD | PMID:20938992 |
| genistein | multiple interactions | ISO | RGD:730873 | 6480464 | ESR2 promotes the reaction [Genistein results in decreased expression of ANXA1 protein] | CTD | PMID:20884965 |
| genistein | decreases expression | ISO | RGD:730873 | 6480464 | Genistein results in decreased expression of ANXA1 protein | CTD | PMID:20884965 |
| graphite | increases expression | ISO | RGD:730873 | 6480464 | Graphite results in increased expression of ANXA1 protein | CTD | PMID:22157353 |
| hexachlorobenzene | increases expression | ISO | RGD:2118 | 6480464 | Hexachlorobenzene results in increased expression of ANXA1 mRNA | CTD | PMID:15159207 |
| hyaluronic acid | decreases expression | ISO | RGD:2118 | 6480464 | Hyaluronic Acid analog results in decreased expression of ANXA1 protein | CTD | PMID:23178681 |
| hyaluronic acid | multiple interactions | ISO | RGD:2118 | 6480464 | Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of ANXA1 protein] | CTD | PMID:23178681 |
| hydrogen peroxide | multiple interactions | ISO | RGD:2118 | 6480464 | Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of ANXA1 protein] | CTD | PMID:23178681 |
| hydrogen peroxide | decreases expression | ISO | RGD:2118 | 6480464 | Hydrogen Peroxide results in decreased expression of ANXA1 protein | CTD | PMID:23178681 |
| ibuprofen | affects expression | ISO | RGD:730873 | 6480464 | Ibuprofen affects the expression of ANXA1 mRNA | CTD | PMID:17070997 |
| iron atom | decreases expression | ISO | RGD:2118 | 6480464 | Iron deficiency results in decreased expression of ANXA1 mRNA | CTD | PMID:19821111 |
| isoprenaline | multiple interactions | EXP | | 6480464 | ANXA1 affects the reaction [Isoproterenol results in decreased secretion of IL6 protein] | CTD | PMID:16835395 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of ANXA1 mRNA | CTD | PMID:20003209 |
| kojic acid | decreases expression | ISO | RGD:730873 | 6480464 | kojic acid results in decreased expression of ANXA1 mRNA | CTD | PMID:16595896 |
| L-ascorbic acid | multiple interactions | ISO | RGD:730873 | 6480464 | [Quercetin co-treated with Ascorbic Acid] results in increased expression of ANXA1 mRNA | CTD | PMID:17639512 |
| L-ascorbic acid | increases expression | ISO | RGD:2118 | 6480464 | Ascorbic Acid results in increased expression of ANXA1 mRNA | CTD | PMID:15372504 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANXA1 mRNA | CTD | PMID:20938992 |
| lead diacetate | decreases expression | ISO | RGD:2118 | 6480464 | lead acetate results in decreased expression of ANXA1 mRNA; more ... | CTD | PMID:11578147 |
| lead(0) | affects activity | ISO | RGD:2118 | 6480464 | Lead affects the activity of ANXA1 protein | CTD | PMID:20655937 |
| lead(0) | multiple interactions | ISO | RGD:2118 | 6480464 | Lead affects the reaction [[Magnesium co-treated with Adenosine Triphosphate] affects the activity of ANXA1 protein] | CTD | PMID:20655937 |
| lithocholic acid | increases expression | EXP | | 6480464 | Lithocholic Acid results in increased expression of ANXA1 mRNA | CTD | PMID:20359477 |
| magnesium atom | multiple interactions | ISO | RGD:2118 | 6480464 | arsenite affects the reaction [[Magnesium co-treated with Adenosine Triphosphate] affects the activity of ANXA1 protein]; more ... | CTD | PMID:20655937 |
| miconazole | decreases expression | ISO | RGD:2118 | 6480464 | Miconazole results in decreased expression of ANXA1 mRNA | CTD | PMID:22262564 |
| mifepristone | multiple interactions | ISO | RGD:730873 | 6480464 | Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [EGFR protein binds to ANXA1 protein modified form]]; more ... | CTD | PMID:10807665 |
| mifepristone | increases expression | ISO | RGD:730873 | 6480464 | Mifepristone results in increased expression of ANXA1 mRNA | CTD | PMID:17584828 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:2118 | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ANXA1 mRNA | CTD | PMID:18164116 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:2118 | 6480464 | Diethylnitrosamine results in increased expression of ANXA1 protein | CTD | PMID:20935162 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:2118 | 6480464 | Diethylnitrosamine results in increased expression of ANXA1 mRNA | CTD | PMID:19638242 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:2118 | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ANXA1 protein | CTD | PMID:20935162 |
| nickel sulfate | increases expression | ISO | RGD:730873 | 6480464 | nickel sulfate results in increased expression of ANXA1 mRNA | CTD | PMID:16314067 |
| ochratoxin A | increases expression | ISO | RGD:2118 | 6480464 | ochratoxin A results in increased expression of ANXA1 mRNA | CTD | PMID:23358140 |
| ouabain | affects expression | ISO | RGD:730873 | 6480464 | Ouabain affects the expression of ANXA1 protein | CTD | PMID:17268060 |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of ANXA1 mRNA | CTD | PMID:12763052 |
| paclitaxel | increases response to substance | ISO | RGD:730873 | 6480464 | ANXA1 protein results in increased susceptibility to Paclitaxel | CTD | PMID:16734730 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of ANXA1 mRNA | CTD | PMID:18544908 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of ANXA1 mRNA | CTD | PMID:17562736 |
| perfluorooctanoic acid | increases expression | ISO | RGD:2118 | 6480464 | perfluorooctanoic acid results in increased expression of ANXA1 mRNA | CTD | PMID:16221955 |
| phenobarbital | multiple interactions | ISO | RGD:2118 | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ANXA1 protein | CTD | PMID:20935162 |
| phenobarbital | affects expression | ISO | RGD:730873 | 6480464 | Phenobarbital affects the expression of ANXA1 mRNA | CTD | PMID:19159669 |
| phorbol 13-acetate 12-myristate | increases expression | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of ANXA1 mRNA | CTD | PMID:19945525 |
| phosgene | affects expression | EXP | | 6480464 | Phosgene affects the expression of ANXA1 mRNA | CTD | PMID:16300373 |
| prostaglandin E2 | multiple interactions | ISO | RGD:730873 | 6480464 | ANXA1 protein inhibits the reaction [Lipopolysaccharides results in increased abundance of Dinoprostone] | CTD | PMID:21777521 |
| quercetin | multiple interactions | ISO | RGD:730873 | 6480464 | [Quercetin co-treated with Ascorbic Acid] results in increased expression of ANXA1 mRNA | CTD | PMID:17639512 |
| quercetin | decreases expression | ISO | RGD:2118 | 6480464 | Quercetin results in decreased expression of ANXA1 mRNA | CTD | PMID:18095365 |
| quercetin | increases expression | ISO | RGD:730873 | 6480464 | Quercetin results in increased expression of ANXA1 protein | CTD | PMID:15221776 |
| quinoline | increases expression | ISO | RGD:730873 | 6480464 | quinoline analog results in increased expression of ANXA1 protein | CTD | PMID:18645022 |
| rosiglitazone | affects expression | ISO | RGD:730873 | 6480464 | rosiglitazone affects the expression of ANXA1 protein | CTD | PMID:19556978 |
| simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of ANXA1 protein | CTD | PMID:14973129 |
| tacrolimus hydrate | increases expression | ISO | RGD:2118 | 6480464 | Tacrolimus results in increased expression of ANXA1 | CTD | PMID:20484890 |
| vancomycin | decreases expression | EXP | | 6480464 | Vancomycin results in decreased expression of ANXA1 mRNA | CTD | PMID:18930951 |
| zinc atom | affects expression | ISO | RGD:730873 | 6480464 | Zinc affects the expression of ANXA1 mRNA | CTD | PMID:16979875 |
| zinc(0) | affects expression | ISO | RGD:730873 | 6480464 | Zinc affects the expression of ANXA1 mRNA | CTD | PMID:16979875 |